The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The European Medicines Agency’s positive opinion for ivermectin-albendazole for treating soil-transmitted helminth infections ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

Researchers have made strides creating strong, long-lasting imitation muscle as science fiction slowly evolves into fact.

Increased menstrual blood loss can be hard to measure and may detract from a woman’s quality of life, but a range of ...

Everything's disrupted.’ It's not quite that simple.” Author, executive advisor, and chief futurist at Futurist.com, Nikolas Badminton, talks healthcare in 2050.

A recent survey revealed that many patients were worried about the physical effects of radiation, and more than one third ...

Women’s antidepressant use dropped by nearly half during pregnancy without a corresponding increase in psychotherapy use and ...

Exercise and nutritional prehabilitation are associated with lower complication rates and possible improvements in other ...